Small secondary-market sale by a board member who is not an executive of TXG — negligible dilution signal. The $184K amount is immaterial relative to daily trading volume in TXG. Monitor Form 4 filings to confirm whether the sale executed, but this alone warrants no trading action.
Price Chart
Executive Summary
Board member Shehnaaz Suliman (ultragenyx CFO) filed intent to sell 5,723 shares of TXG Class A common stock worth approximately $184,395, executed through JP Morgan. Shares were acquired from RSU vesting over 2021-2024. The proposed sale is small relative to market cap and Suliman's likely holdings, and follows a pattern of insider selling at 10x Genomics.
Key Facts
- Filer: Shehnaaz Suliman, board member and CFO of ultragenyx (not TXG employee)
- Proposed sale: 5,723 shares of Class A common stock
- Estimated value: $184,395.06 (based on ~$32.23/sh)
- Broker: JP Morgan Securities LLC
- Shares acquired from RSU vesting between 2021 and 2024 (compensation-based)
- Filing date: June 16, 2026; proposed sale date also June 16, 2026
- Form 144 is intent to sell — actual sale not guaranteed
Financial Impact
approximately $184,000, representing less than 0.005% of TXG's $4.1B market cap
Risk Factors
- Insider selling from board members can indicate waning conviction, though here the scale is trivial
- TXG has seen recent insider selling ($1.4M over 30d) — this filing adds to that pattern modestly
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001968582-26-000625 |
| Document: 0001968582-26-000625-index.html | 0001968582-26-000625 |
| Document: 0001968582-26-000625.txt | 0001968582-26-000625 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 20d ago | Insider Cluster | $70.11 $79.10 | ▲ +12.82% | ▲ +12.72% | $92.04 (+31.27%) |
Sep 3, 2026 28d ago | 144 | $63.22 $68.59 | ▼ −8.49% | ▼ −9.64% | $92.04 (−45.58%) |
Aug 28, 2026 4w ago | Insider Cluster | $62.45 $65.60 | ▲ +5.04% | ▲ +5.19% | $92.04 (+47.37%) |
Aug 26, 2026 5w ago | Insider Cluster | $64.85 $63.22 | ▼ −2.51% | ▼ −2.78% | $92.04 (+41.92%) |
Aug 20, 2026 6w ago | Institutional Cluster | $63.87 $64.85 | ▲ +1.53% | ▲ +0.42% | $92.04 (+44.10%) |
Aug 19, 2026 6w ago | Court Ruling | $62.19 $64.26 | ▼ −3.33% | ▼ −3.72% | $92.04 (−47.99%) |
Aug 17, 2026 6w ago | Insider Cluster | $57.99 $63.80 | ▲ +10.02% | ▲ +11.21% | $92.04 (+58.71%) |
Jul 5, 2026 12w ago | Institutional Cluster | $40.00 $42.73 | ▲ +6.83% | ▲ +6.34% | $92.04 (+130.09%) |
Jun 16, 2026 15w ago | 144 | $32.13 $34.60 | ▲ +7.69% | ▲ +8.73% | $92.04 (+186.45%) |
May 27, 2026 18w ago | Insider Cluster | $27.99 $33.50 | ▲ +19.69% | ▲ +19.37% | $92.04 (+228.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access